FPL
BIO icon

Fortress Private Ledger’s Bio-Rad Laboratories Class A BIO Stock Holding History

Fortress Private Ledger’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$431K Buy
1,546
+197
+15% +$56.7K 0.13% 146
2025
Q4 		$409K Buy
1,349
+378
+39% +$118K 0.13% 138
2025
Q3 		$272K Buy
+971
New +$264K 0.1% 166

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fortress Private Ledger's BIO Position: Q1 2026 in Review

Fortress Private Ledger increased its Bio-Rad Laboratories Class A (BIO) stake by 15% in Q1 2026, buying an estimated $56.7K and bringing the position to 1,546 shares worth $431K. The position accounts for 0.13% of the portfolio, ranked #146.

Fortress Private Ledger first reported a position in BIO in Q3 2025 and has held it in 3 quarters since. 391 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Fortress Private Ledger held 1,546 shares of Bio-Rad Laboratories Class A worth $431K as of Q1 2026.
  • Fortress Private Ledger bought 197 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $56.7K.
  • Bio-Rad Laboratories Class A made up 0.13% of Fortress Private Ledger's portfolio in Q1 2026, its #146 holding.
  • Fortress Private Ledger first reported a position in Bio-Rad Laboratories Class A in Q3 2025 and has held it in 3 quarters since.
  • 391 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Fortress Private Ledger's 13F filing for Q1 2026, filed 13 May 2026.